BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36939203)

  • 1. Comparative analysis of the functional properties of human and mouse ferroportin.
    Azucenas CR; Ruwe TA; Bonamer JP; Qiao B; Ganz T; Jormakka M; Nemeth E; Mackenzie B
    Am J Physiol Cell Physiol; 2023 May; 324(5):C1110-C1118. PubMed ID: 36939203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mice overexpressing hepcidin suggest ferroportin does not play a major role in Mn homeostasis.
    Jin L; Frazer DM; Lu Y; Wilkins SJ; Ayton S; Bush A; Anderson GJ
    Metallomics; 2019 May; 11(5):959-967. PubMed ID: 30888356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-function analysis of ferroportin defines the binding site and an alternative mechanism of action of hepcidin.
    Aschemeyer S; Qiao B; Stefanova D; Valore EV; Sek AC; Ruwe TA; Vieth KR; Jung G; Casu C; Rivella S; Jormakka M; Mackenzie B; Ganz T; Nemeth E
    Blood; 2018 Feb; 131(8):899-910. PubMed ID: 29237594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional properties of human ferroportin, a cellular iron exporter reactive also with cobalt and zinc.
    Mitchell CJ; Shawki A; Ganz T; Nemeth E; Mackenzie B
    Am J Physiol Cell Physiol; 2014 Mar; 306(5):C450-9. PubMed ID: 24304836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The flatiron mutation in mouse ferroportin acts as a dominant negative to cause ferroportin disease.
    Zohn IE; De Domenico I; Pollock A; Ward DM; Goodman JF; Liang X; Sanchez AJ; Niswander L; Kaplan J
    Blood; 2007 May; 109(10):4174-80. PubMed ID: 17289807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of hepcidin and ferroportin in full term placenta of pregnant cows.
    Roperto S; Russo V; Urraro C; Cutarelli A; Perillo A; De Falco F; Roperto F
    Theriogenology; 2017 Nov; 103():90-97. PubMed ID: 28780484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferroportin deficiency impairs manganese metabolism in flatiron mice.
    Seo YA; Wessling-Resnick M
    FASEB J; 2015 Jul; 29(7):2726-33. PubMed ID: 25782988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron Availability in Tissue Microenvironment: The Key Role of Ferroportin.
    Gammella E; Correnti M; Cairo G; Recalcati S
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33804198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for dimerization of ferroportin in a human hepatic cell line using proximity ligation assays.
    Rishi G; Secondes ES; Wallace DF; Subramaniam VN
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32301493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mice with hepcidin-resistant ferroportin accumulate iron in the retina.
    Theurl M; Song D; Clark E; Sterling J; Grieco S; Altamura S; Galy B; Hentze M; Muckenthaler MU; Dunaief JL
    FASEB J; 2016 Feb; 30(2):813-23. PubMed ID: 26506980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of ubiquitination in hepcidin-independent and hepcidin-dependent degradation of ferroportin.
    De Domenico I; Lo E; Yang B; Korolnek T; Hamza I; Ward DM; Kaplan J
    Cell Metab; 2011 Nov; 14(5):635-46. PubMed ID: 22019085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of cellular iron deficiency in controlling iron export.
    Link C; Knopf JD; Marques O; Lemberg MK; Muckenthaler MU
    Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129829. PubMed ID: 33340587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ferroportin disease mutations influence manganese accumulation and cytotoxicity.
    Choi EK; Nguyen TT; Iwase S; Seo YA
    FASEB J; 2019 Feb; 33(2):2228-2240. PubMed ID: 30247984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance of ferroportin to hepcidin binding causes exocrine pancreatic failure and fatal iron overload.
    Altamura S; Kessler R; Gröne HJ; Gretz N; Hentze MW; Galy B; Muckenthaler MU
    Cell Metab; 2014 Aug; 20(2):359-67. PubMed ID: 25100063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis of ferroportin inhibition by minihepcidin PR73.
    Wilbon AS; Shen J; Ruchala P; Zhou M; Pan Y
    PLoS Biol; 2023 Jan; 21(1):e3001936. PubMed ID: 36649314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of the hepcidin/ferroportin regulatory circuitry causes low axial bone mass in mice.
    Ledesma-Colunga MG; Baschant U; Fiedler IAK; Busse B; Hofbauer LC; Muckenthaler MU; Altamura S; Rauner M
    Bone; 2020 Aug; 137():115400. PubMed ID: 32380257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis.
    Donovan A; Lima CA; Pinkus JL; Pinkus GS; Zon LI; Robine S; Andrews NC
    Cell Metab; 2005 Mar; 1(3):191-200. PubMed ID: 16054062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ironing out Ferroportin.
    Drakesmith H; Nemeth E; Ganz T
    Cell Metab; 2015 Nov; 22(5):777-87. PubMed ID: 26437604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An essential cell-autonomous role for hepcidin in cardiac iron homeostasis.
    Lakhal-Littleton S; Wolna M; Chung YJ; Christian HC; Heather LC; Brescia M; Ball V; Diaz R; Santos A; Biggs D; Clarke K; Davies B; Robbins PA
    Elife; 2016 Nov; 5():. PubMed ID: 27897970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Guanosine 5'-diphosphate as Potential Iron Mobilizer: Preventing the Hepcidin-Ferroportin Interaction and Modulating the Interleukin-6/Stat-3 Pathway.
    Angmo S; Tripathi N; Abbat S; Sharma S; Singh SS; Halder A; Yadav K; Shukla G; Sandhir R; Rishi V; Bharatam PV; Yadav H; Singhal NK
    Sci Rep; 2017 Jan; 7():40097. PubMed ID: 28054602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.